sortieren
Medicine and Dentistry
Androgen Deprivation Therapy
11%
Biochemical Recurrence
11%
Biodistribution
11%
Biological Marker
34%
Bladder Cancer
24%
Body Mass Index
11%
Cancer Prognosis
11%
Cancer Registry
11%
Cell-Free DNA
11%
Chloroplast DNA
11%
Clinical Significance
11%
Colonoscopy
11%
Comorbidity
5%
Conjugate
18%
Cross-Validation
7%
Cystectomy
12%
Cytoreductive Surgery
11%
Decision Making
17%
Diagnostic Performance
12%
Dietary Supplement
5%
Diseases
9%
Enfortumab Vedotin
11%
Fluorine-18
5%
Frailty
5%
Gallium 68
66%
Geriatrics
5%
Germinoma
11%
Histopathology
6%
Hospital Management
16%
Hydronephrosis
5%
Kidney Stone
11%
Lymph Node Metastasis
22%
Lymphocyte
22%
Lymphocyte Antigen Receptor
11%
Magnetic Resonance Imaging
5%
Malignant Neoplasm
6%
Meta-Analysis
11%
Metastatic Carcinoma
16%
Methylation
11%
Morphology
11%
Muscle Invasive Bladder Cancer
5%
Neoplasm
30%
Nephrostomy
13%
Neutrophil
22%
Non Muscle Invasive Bladder Cancer
25%
Overall Survival
11%
Patient Selection
11%
Percutaneous Nephrolithotomy
5%
PET-MRI
27%
Polyethylene Terephthalate
27%
Polyp
5%
Positron Emission Tomography
39%
Positron Emission Tomography-Computed Tomography
24%
Prognostic Factor
5%
Progression Free Survival
6%
Prostate Cancer
81%
Prostate Specific Membrane Antigen
44%
Prostatectomy
22%
Protein Expression
11%
Radioactive Tracer
12%
Real-World Evidence
11%
Recurrent Disease
10%
Risk Stratification
5%
Seasonal Variation
11%
Systematic Review
11%
Systemic Therapy
11%
Transitional Cell Carcinoma
8%
Ureter Stone
11%
Urinary Diversion
16%
Urolithiasis
11%
Urology
16%
Urothelial Cancer
14%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
11%
Biochemical Recurrence
11%
Biodistribution
11%
Biological Marker
23%
Bladder Cancer
11%
Cancer Prognosis
11%
Castration Resistant Prostate Cancer
24%
Chloroplast DNA
11%
Circulating Tumor DNA
12%
Comorbidity
5%
Cross-Sectional Study
11%
Dietary Supplement
5%
Diseases
13%
Enfortumab Vedotin
11%
Fluorine 18
5%
Frailty
5%
Gallium 68
77%
Kidney Stone
11%
Lutetium 177
11%
Lymph Node Metastasis
11%
Lymphocyte Antigen Receptor
11%
Malignant Neoplasm
14%
Neoplasm
34%
Nephrolithiasis
11%
Non Muscle Invasive Bladder Cancer
25%
Overall Survival
22%
Polyethylene Terephthalate
100%
Progression Free Survival
12%
Prostate Cancer
73%
Prostate Specific Antigen
11%
Prostate Specific Membrane Antigen
44%
Radioligand
12%
Recurrent Disease
13%
Solid Malignant Neoplasm
12%
Tracer
12%
Ureter Stone
11%
Biochemistry, Genetics and Molecular Biology
Antigen Expression
8%
Blood Plasma
7%
Body Mass
11%
Chloroplast DNA
11%
Circulating Tumor DNA
23%
Conjugate
11%
Copy-Number Variation
11%
Cross Sectional Study
11%
Decision Making
11%
DNA Analysis
6%
English (Language)
11%
Genome Instability
11%
Magnetic Resonance Imaging
16%
Methylation
11%
Molecular Biology
11%
Nomogram
11%
Optical Density
5%
Overall Survival
12%
Positron Emission Tomography
29%
Positron Emission Tomography-Computed Tomography
22%
Prospective Study
5%
Prostate-Specific Antigen
6%
Protein Expression
11%
Radioligand
11%
Tumor Volume
15%